Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Rises By 52.3%

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the target of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 169,500 shares, a growth of 52.3% from the January 31st total of 111,300 shares. Currently, 10.8% of the company’s shares are short sold. Based on an average daily trading volume, of 2,710,000 shares, the short-interest ratio is presently 0.1 days.

NLS Pharmaceutics Stock Down 10.1 %

Shares of NLSP stock traded down $0.18 during trading on Tuesday, hitting $1.60. 82,899 shares of the stock traded hands, compared to its average volume of 3,493,938. NLS Pharmaceutics has a 52-week low of $1.47 and a 52-week high of $18.39. The firm’s fifty day moving average price is $2.06 and its 200-day moving average price is $2.36.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).